Urine Drug Testing in Clinical Practice:Pearls & Pitfalls
	Legal Terms and Conditions
	Urine Drug Testing in Clinical Practice: Slide 3
	Slide Contributors
	Goal
	Objectives
	Background
	Background
	Federally Regulated Urine Drug Testing
	Nonregulated Urine Drug Testing
	Urine Drug Testing in Clinical Practice
	Urine Drug Testing in Clinical Practice
	Urine Drug Testing in Clinical Practice
	Urine Drug Testing in Clinical Practice
	Specimen Collection in Clinical Practice
	Urine Drug Testing Process
	Urine Drug Testing Process: Immunoassays
	Urine Drug Testing Process: Confirmatory
	GC/MS of Oxycodone
	Drug-Class–Specific Windows of Detection in Urine
	Interpretation of UDT Results
	Interpretation of UDT Results
	“Opiate” Immunoassay Screens
	Metabolism* of Opioids
	Opiate Screens
	Common Error of Interpretation
	Common Error of Interpretation
	Medical Explanations for Positive Results: Opiates
	Medical Explanations for Positive Results: Cocaine
	Medical Explanations for Positive Results
	Medical Explanations for Positive Results
	False-Positive Possibilities/Myths: Marijuana
	False-Positive Results
	UDT Results Reported as“None Detected”
	False-Negative Results
	Case Study 1
	Case Study 1
	Case Study 1: Possible Outcomes of Urine Drug Testing
	Case Study 1: Second Outcome
	Case Study 1: Third Outcome
	Case Study 1: Fourth Outcome
	Case Study 2
	Case Study 2
	Case Study 3
	Case Study 3
	Emerging Technologies for Drug Testing
	Emerging Technologies for Drug Testing
	Relative Drug Detection Times in Biologic Specimens
	Summary: Before You Order a UDT
	Summary: Interpretation of UDT Results
	Conclusion

• Evidence-based Pain Therapy
• Headache and Craniofacial Pain Disorders I
• Acute Postoperative Pain: Context, Outcomes and Clinical Interventions
• Neuropathic Pain I
• Cancer Pain